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The antigenic site of dengue type 2 virus (DEN2)-neutralizing monoclonal antibody (mab) 3H5 was investigated by muta-
tional analysis. Sequence comparisons indicated that much of the 12-amino-acid sequence extending from position 386 to
397 of the DEN2 envelope glycoprotein (E) previously thought to represent the DEN2-specific mab 3H5 binding site was
also present in some dengue type 1, 3, or 4 virus strains. However, the region occupied by the Glu-Pro-Gly sequence at
upstream positions 383 to 385 was completely conserved among DEN2 strains, but divergent in other serotype viruses,
suggesting that this sequence might be part of the antigenic site of mab 3H5. We investigated this possibility by employing
the previously constructed chimeric DEN2(PreM-E)/DEN4 cDNA clone to produce viable mutants bearing DEN2 PreM and
E sequences that could be analyzed for binding to and neutralization by mab 3H5. We constructed 13 such DEN2 mutants
that contained a single amino acid substitution in the region between positions 383 and 393 of DEN2 E. Each single
substitution in the region spanning positions 386 through 393 of DEN2 yielded a virus that was as reactive with mab 3H5
as the parental chimeric virus. These results are consistent with the extent of sequence conservation in the region. In
contrast, 5 of 6 mutants that sustained an amino acid substitution at position 383, 384, or 385 failed to react with mab 3H5
as detected by immunofluorescence assay and failed to be neutralized by the mab. Interestingly, each of the 5 mab-
resistant DEN2 mutants also exhibited reduced mouse neurovirulence compared to parental chimeric DEN2 when inoculated
intracerebrally. These observations suggest that the Glu-Pro-Gly sequence at positions 383–385 of the DEN2 E is a
component of the site against which mab 3H5 is directed. In the recently determined three-dimensional structure of the
related tick-borne encephalitis virus E, the Glu-Pro-Gly sequence would be located on the lateral surface of the immunoglobu-
lin-like domain that is proposed to bind to the host cell receptor. q 1996 Academic Press, Inc.
INTRODUCTION has been the subject of considerable study (Heinz et al.,
1983; Kimura-Kuroda et al., 1986; Bray et al., 1989; Men
The flavivirus genus of the Flaviviridae contains some et al., 1991). According to the antigenic model proposed
70 serologically related viruses, most of which are mos- earlier for the tick-borne encephalitis virus (TBEV) E,
quito- or tick-borne and are also able to replicate in hu- there were at least three distinct domains (Henchal et
mans. Flaviviruses have a relatively simple enveloped al., 1985; Heinz, 1986; Nowak and Wengler, 1987). These
virion structure, consisting of a capsid protein (C), a small antigenic domains can now be assigned to separate re-
membrane protein (M), and an envelope protein (E) (Stol- gions in the three-dimensional structure of the TBEV E
lar, 1969). The structural envelope protein E, which is recently determined by crystallography (Rey et al., 1995).
approximately 500 amino acids in length and glycosyl- The TBEV E structure has a unique feature in which each
ated in a majority of flaviviruses, plays a central role in subunit of dimeric E folds into three different structural
mediating various steps of viral infection. For example, domains, designated as the central region (domain I),
the E protein is responsible for viral attachment to recep- the dimerization region (domain II), and the immunoglob-
tors on the cell surface and targeting the virus to specific ulin-like module (domain III), spreading across a rela-
cells or hosts, fusion with the lysosomal membranes of tively flat and elongated plane. These new insights into
acidic vesicles following viral entry, viral assembly, and the folding of the individual domains in the flavivirus E
exit of the mature virions from infected cells. Flavivirus have provided greater understanding of the structural,
E is also the major antigen responsible for inducing a functional, and antigenic relationships of this immuno-
protective immune response in the infected host. During dominant potective antigen.
the past few years, the antigenic structure and the func- Among flaviviruses, the dengue viruses (DEN1 – 4 ser-
tional role of E of several medically important flaviviruses otypes) are most important in terms of wide geographi-
cal distribution and extensive human morbidity which
is estimated to involve hundreds of millions every year1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (301) 496-8312. (Monath, 1994). Monoclonal antibodies (mabs) directed
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against each of the four dengue virus serotypes have structed a series of chimeric DEN2 mutants to map the
antigenic determinant of mab 3H5 on DEN2 E. Using thisbeen prepared and have proved valuable for diagnostic
purposes (Gentry et al., 1982; Henchal et al., 1983). approach, we observed that five of six DEN2 mutants
containing a single amino acid substitution in the Glu-These mabs were characterized with respect to their
ability to neutralize dengue virus, to inhibit hemaggluti- Pro-Gly sequence at position 383, 384, or 385 of E failed
to react or reacted weakly with mab 3H5, were com-nation, or to simply bind to dengue virus. Dengue virus
type-specific, dengue virus subcomplex- or complex- pletely or partially resistant to neutralization by the mab,
and exhibited reduced neurovirulence for mice. In thespecific, or flavivirus group broadly reactive antigenic
determinants have been identified using a large panel three-dimensional structure of the flavivirus E, these
three amino acids can tentatively be positioned on theof DEN2 mabs. At least three distinct antigenic domains
have been localized on the dengue virus E (Gentry et lateral surface of the immunoglobulin-like domain that is
proposed to bind the virus to host cell receptors (Rey etal., 1982; Henchal et al., 1985). Amino acid homology is
approximately 60 – 70% among the Es of different den- al., 1995).
gue virus serotypes. In contrast, homology between
DEN4 E and its distantly related TBEV E is only 36% MATERIALS AND METHODS
(Chambers et al., 1990). Significantly, all 12 cysteine
Viruses, cultured cells, and antibodiesresidues that form the six disulfide bridges in each flavi-
virus E are conserved. DEN4 – TBEV interflavivirus chi- The mouse-adapted neurovirulent strain of human
meras that contain the TBEV C-PreM-E or PreM-E genes DEN2 New Guinea C (NGC) virus, isolated by serial intra-
replacing the corresponding DEN4 genes constructed cerebral passage (Sabin, 1952; Schlesinger and Frankel,
from full-length DEN4 cDNA were shown to be infec- 1952), was described in a previous report (Bray and Lai,
tious (Pletnev et al., 1992). These observations provide 1991). Mosquito C6/36 cells were grown in Eagle’s mini-
direct evidence suggesting the functional and structural mum essential medium (MEM) supplemented with 10%
similarity between dengue virus E and TBEV E. fetal calf serum (FCS). The chimeric DEN2(PreM-E)/
Attempts to map the antigenic determinants on dengue DEN4 cDNA clone was constructed from DEN4 cDNA by
virus E were made earlier by analysis of the binding of replacing the DEN4 PreM-E genes with the DEN2 NGC
various mabs to a series of synthetic peptides or recom- PreM-E genes between the PstI (DEN2 nt 400) and the
binant DNA-expressed peptide fragments spanning XhoI (corresponding to DEN4 nt 2342) sites (Bray and Lai,
DEN2 E (Roehrig et al., 1990; Megret et al., 1992; Trirawa- 1991; Pletnev et al., 1992). Chimeric DEN2 was recovered
tanapong et al., 1992). In one study, mabs were tested from C6/36 cells transfected with the RNA transcripts of
for their ability to bind these peptides by immunoblotting chimeric cDNA. In this report, the parental chimeric
(Megret et al., 1992). Surprisingly, a similar peptide bind- DEN2 is referred as DEN2 for simplicity. Mab 3H5 pre-
ing pattern was observed for most neutralizing mabs. pared against DEN2 NGC was kindly supplied by Dr.
Binding to a large peptide fragment spanning amino Putnak (Walter Reed Army Institute of Research, Wash-
acids (aa) 298–397 was detected, but not to a series of ington, DC). DEN2 or DEN4 hyperimmune mouse ascitic
smaller peptides, such as aa 298–385 or aa 304–397 of fluid (HMAF) was purchased from the American Type
the DEN2 E sequence. Binding of mabs appeared to Culture Collection (Rockville, MD).
be dependent on peptide folding produced by disulfide
bonds. It was concluded that these neutralizing mabs, Construction of DEN2 mutants containing amino acid
including mab 3H5, recognized sites in the DEN2 E that substitutions in E
involved discontinuous sequences. Mab 3H5 was shown
to neutralize DEN2 at high titer, but its hemagglutination- Oligonucleotide-directed mutagenesis was performed
to introduce a single amino acid substitution in the regioninhibition activity was low (Gentry et al., 1982). In another
study, the antigenic site of mab 3H5 was analyzed in a spanning aa 383–393 of the DEN2 E gene that is con-
tained within the intermediate p5*DEN2(PreM-E)/DEN4similar manner, and the data were interpreted as indicat-
ing that mab 3H5 reacted with a linear sequence within cDNA clone (Bray and Lai, 1991). The chimeric cDNA
vector was modified by removing the SstI site at DEN4aa 386–397 of DEN2 E (Trirawatanapong et al., 1992).
Previously, we employed DEN4 cDNA to construct in- nt 3033 and creating a new SstI site at DEN2 nt 2121
through a silent mutation near the sequence targeted fortertypic dengue chimeric viruses that contained the C-
PreM-E or only the PreM-E genes of a mouse neuroviru- mutation. Unmodified parental chimeric cDNA was used
as the template for PCR to generate the DNA fragmentslent DEN2 mutant that replaced the corresponding genes
of DEN4 (Bray and Lai, 1991). As expected, these chime- containing the targeted mutations. For example, to create
a mutant containing Ala substituting for Gln386 in E, oligoric viruses that expressed DEN2 structural proteins ex-
hibited DEN2 antigenic specificity. The chimeras also 239 (DEN4 nt 18–44) was used as the positive-strand
primer and oligo CTCAATCATTTGGCCGATAGAGCTC-exhibited the mouse neurovirulence of the DEN2 mutant
from which the structural protein genes were derived. CCTTTCTTAAACCAGTTGAGCTTCAATGCTCCCGGCTC
containing the target codon (underlined) and a flankingUsing the DEN2(PreM-E)/DEN4 cDNA clone, we con-
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SstI site (double-underlined) was used as the negative- reaction mixture was titered by a plaque assay on C6/
36 cells as described above.strand primer. Following cleavage with Bgl II and SstI,
the PCR DNA fragment was used to replace the parental
Detection of mab 3H5 binding to oligopeptides bysequence in the intermediate cDNA vector. As was de-
ELISAscribed earlier (Bray and Lai, 1991), the 3* DEN4 DNA
fragment between the XhoI and Asp 718 sites was subse- DEN2 E oligopeptides, each 12 amino acids in length,
quently added to generate full-length chimeric DEN2 were synthesized on a solid-phase carrier and kindly
(PreM-E)/DEN4 cDNA. supplied by Dr. Coligan (Biological Resources Branch,
NIAID). Each oligopeptide to be tested was coated on aIsolation of DEN2 mutants
96-well microtiter plate at 5 mg/well in the presence of
The procedure for RNA transcription and transfection 0.1 M carbonate buffer, pH 9.6. After extensive washing
of mosquito C6/36 cells with the RNA transcripts was as with phosphate-buffered saline (PBS) containing 3% bo-
described (Lai et al., 1991). Nine days after transfection, vine serum albumin, DEN2 HMAF or mab 3H5 diluted in
C6/36 cells in a T25 flask were transferred to a T75 flask PBS plus 0.05% Tween 20 was added. Binding of antibod-
and a chamber slide. Three days later, cells in the cham- ies to the peptides was detected using peroxidase-conju-
ber slide were fixed with methanol and reacted with gated goat anti-mouse IgG (Kirkegaard and Perry, Gaith-
DEN2 HMAF in an indirect immunofluorescence assay ersburg, MD) and ortho-phenylenediamine. The reaction
(IFA). If IFA showed 80% or more of the cells stained was stopped by addition of 2 N H2SO4 and the color
positively, the virus in the medium fluid of the T75 flask intensity read at 490 nm in an ELISA reader. A DEN4 E
was collected and the medium adjusted to contain 10% peptide spanning aa 258–271 for reaction with DEN4
FCS prior to storage at 0707. Each mutant was titered HMAF was included in the analysis as a positive control.
by a plaque assay on C6/36 cells (Bancroft et al., 1975).
DEN2 mouse neurovirulenceBriefly, monolayers of C6/36 cells were inoculated with
serial 10-fold dilutions of virus and an overlay of SeaKem
Parental DEN2 chimera and its derived mutants con-
GTG agarose containing Hanks’ balanced salt solution
taining an amino acid substitution in E were analyzed
and lactalbumin hydrolysate plus 10% FCS. Cells were
for mouse neurovirulence as described previously (Ka-
stained with neutral red 6 days after infection and the
wano et al., 1993). Three-day-old outbred Swiss mice, in
number of plaques was scored the following day. If the
groups of 8 to 11, were inoculated intracerebrally with
virus titer was lower than 4 1 105 PFU/ml, an additional
each test virus at a dose of 100 or 1000 PFU in 25 ml
passage in C6/36 cells was performed to amplify the
MEM plus 0.25% human serum albumin. Inoculated mice
virus.
were observed for signs of encephalitis, such as ruffled
hair, hunched back, and paralysis. The moribund animalsRadioimmunoprecipitation (RIP)
were sacrificed prior to death and scored during the 28-
Confluent C6/36 cells in a T25 flask were infected with day postinoculation period.
the parental DEN2 chimera or its derived mutant at a
multiplicity of infection of 1.0. Four days after infection, RESULTS
cells were labeled with [35S]methionine in methionine-
Comparison of DEN2 E sequence in the region of thefree medium (50 mCi/ml, sp act 800 Ci/mmol) for 5 hr.
putative mab 3H5 binding site and the correspondingLabeled cells were lysed with 0.5 ml RIPA buffer [1%
sequence in other dengue virus serotypessodium deoxycholate, 1% Nonidet-P40, 0.1% sodium do-
decyl sulfate (SDS), 0.01 M Tris–HCl, pH 7.5, 0.15 M Previously, Gentry et al. prepared a large panel of
NaCl, and phenymethylsulfonyl fluoride, 20 mg/ml]. For mabs against the DEN2 NGC virus and characterized
immunoprecipitation, 0.1 ml of the labeled lysate was these mabs for hemagglutination-inhibition or plaque-
mixed with 2–5 ml of DEN2 HMAF or mab 3H5. The reduction neutralization of each of the four dengue
immunoprecipitate was collected on Pansorbin beads serotype viruses as well as the Japanese encephalitis
and then resolved by SDS–12% polyacrylamide gel elec- virus (Gentry et al., 1982). Among 22 mabs tested, mab
trophoresis. The labeled protein bands on the dried gel 3H5 was unique in that it was specific for DEN2 and
were visualized by fluorography. neutralized the virus at high titer, but exhibited a low
hemagglutination-inhibition titer. The antigenic site of
Plaque reduction neutralization test
mab 3H5 in the DEN2 E was sought using a series
of overlapping peptides expressed from cloned DNAVirus neutralization was tested using a fixed titer of
the test virus in the presence or absence of neutralizing fragments or chemically synthesized oligopeptides
(Megret et al., 1992; Trirawatanapong et al., 1992).mab 3H5. Approximately 100 PFU of the parental chime-
ric DEN2 or each chimeric DEN2 mutant in 1 ml MEM However, these studies yielded conflicting results. In
an attempt to resolve the issue of the antigenic targetcontaining 2% FCS was mixed with mab 3H5 diluted at
1:100 or 1:1000 and incubated for 90 min at 377. The of mab 3H5, we initiated our study by comparing the
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FIG. 1. Comparison between the DEN2 NGC E sequence in and surrounding the putative mab 3H5 binding site and the corresponding sequences
in other DEN2 strains or dengue virus serotypes. The DEN2 NGC E sequence between aa positions 378 and 400 is shown using the single-letter
code. Sequence comparison was made by alignment of the DEN2 NGC sequence (Irie et al., 1989) with the sequence of DEN2 MAL, Malaysia 86
strain (Lewis et al., 1993); DEN2 SRI, Sri Lanka 82 strain (Lewis et al., 1993); DEN2 S1, S1 candidate vaccine strain derived from the PR159 isolate
(Hahn et al., 1988); DEN1 WP, Western Pacific strain (Mason et al., 1987); DEN3 H87, H87 strain (Osatomi et al., 1990); or DEN4 CAR, Caribbean
strain (Zhao et al., 1986). The shaded sequence at aa 386–397 was previously thought to represent the mab 3H5 binding site. A hyphen indicates
an amino acid identical to that present in the DEN2 NGC sequence.
sequence of the putative DEN2 E binding site and the mutations in E. Virus recovered from parental chimeric
corresponding sequence of other DEN2 strains as well cDNA exhibited DEN2 specificity as demonstrated by IFA
as strains of other dengue virus serotypes. Surpris- using mab 3H5. In an attempt to identify the antigenic
ingly, 11 of 12 amino acids in the DEN2 sequence at determinant of mab 3H5, DEN2 mutants were constructed
positions 386 – 397 previously thought to represent the in which an amino acid present in another dengue virus
mab binding site were also present in some or all of serotype was substituted into the parental chimera. Thir-
the dengue type 1, 3, or 4 virus strains (Fig. 1). With teen such mutant constructs were prepared (Table 1).
the exception of the Gln386 to Ala change found in the Seven DEN2 mutants, including Q386A, K388T, L389I,
other three serotypes, the sequence of the DEN2 SRI N390S, N390H, F392Y, and K393R, contained an amino
strain was identical to that of the DEN1 WP strain in acid substitution located at positions 386–393 within the
this region. The sequence of DEN3 H87 was also simi- putative mab 3H5 binding site. Substitution in mutant
lar to that of DEN2 NGC, with three conservative amino L389I, F392Y, or K394R was a conservative amino acid
acid changes, i.e., Leu389Ile, Phe392Tyr, and Lys393Arg. change. The other 6 mutants, i.e., E383G, P384E, P384D,
The sequence of DEN4 CAR was also similar to that P384N, G385K, and G385S, contained a substitution in the
present in DEN2 MAL, except for the Lys388Thr substi- Glu-Pro-Gly sequence located immediately upstream. The
tution and the conservative Lys393Arg change. In con- dengue virus serotypes in which each of the substituted
trast, complete heterotypic divergence from DEN2 in amino acids was present are also listed. In many in-
the other serotypes was present in the upstream se- stances, the sequence difference was present in more
quence at positions 383 – 385. We were intrigued by than one dengue virus serotype.
these observations and therefore considered the pos- RNA transcripts from each of the 13 chimeric DEN2
sibility that the antigenic site of mab 3H5 might actu- cDNA constructs were prepared and used to transfect
ally be located outside aa 386 – 397. As mentioned permissive mosquito C6/36 cells for isolation of viable
above, comparison of the sequences surrounding the mutants. Production of progeny virus in the transfected
putative mab 3H5 binding site indicated that more se- cells was monitored by IFA using DEN2 HMAF. The num-
quence variation existed in the immediate upstream ber of fluorescence-positive cells increased with time
region. Notable sequence differences were seen in and the pattern of increase for each mutant was similar
the aa 383 – 385 region: Glu383 in DEN2 was substituted to that of the parental chimeric DEN2 (data not shown).
with Gly in DEN1, DEN3, or DEN4; Pro384 was substi- This suggested that each of the 13 mutants was not
tuted with Glu in DEN1, Asp in DEN3, or Asn in DEN4;
restricted for growth in cultured cells. Also, it is unlikely
Gly385 was replaced with Lys in DEN1 or DEN3 and that a second site mutation was required for virus recov-
with Ser in DEN4.
ery from the transfected C6/36 cells. The progeny virus
was collected from the culture medium 12–14 days afterConstruction of DEN2 mutants containing amino acid
transfection, when 80–100% of the cells showed thesubstitutions
presence of dengue virus antigens. Subsequently, each
progeny virus was used to infect mosquito C6/36 cellsWe employed chimeric DEN2(PreM-E)/DEN4 cDNA, a
in a chamber slide that was used for detection of bindingderivative of chimeric DEN2(C-PreM-E)/DEN4 constructed
earlier (Bray and Lai et al., 1991), to introduce a series of with mab 3H5 by IFA.
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TABLE 1
Viable Chimeric DEN2(PreM-E)/DEN4 Mutants That Were Constructed to Contain a Single Amino Acid Substitution in E
That Corresponds to the Sequence at This Position in Dengue Type 1, 3, or 4 Virus
Amino acid substitution at indicated position of DEN2 E sequence (positions 383–393) Substituted amino
acid present in E of
Mutant E P G Q L K L N W F K indicated dengue virus
E383G G – – – – – – – – – – DEN1, 3, 4
P384E – E – – – – – – – – – DEN1
P384D – D – – – – – – – – – DEN3
P384N – N – – – – – – – – – DEN4
G385K – – K – – – – – – – – DEN1, 3
G385S – – S – – – – – – – – DEN4
Q386A – – – A – – – – – – – DEN1, 3, 4
K388T – – – – – T – – – – – DEN4
L389I – – – – – – I – – – – DEN3
N390S – – – – – – – S – – – DEN1 or DEN2 (SRI)
N390H – – – – – – – H – – – DEN4 or DEN2 (MAL)
F392Y – – – – – – – – – Y – DEN3
K393R – – – – – – – – – – R DEN3, 4
Note. Construction of the chimeric DEN2 mutants was described under Materials and Methods. Amino acid substitutions were introduced following
site-directed mutagenesis. Codon usage was as follows: Gly383 (GGT), Glu384 (GAA), Asp384 (GAC), Asn384 (AAC), Lys385 (AAA), Ser385 (AGC), Ala386
(GCA), Thr388 (ACG), Ile389 (ATC), Ser390 (AGC), His390 (CAC), Tyr392 (TAT), or Arg393 (AGG).
Reactivity of chimeric DEN2 mutants with mab 3H5 tution in the region between aa positions 386 and 393
were neutralized (i.e., greater than 95% plaque reduction).
Similar to the cells infected with the DEN2 NGC strain
Two other mutants, i.e., K388T and F392Y, were also
or the parental DEN2 chimera, cells infected with each
neutralized at greater than 50% plaque reduction by 1000-
of the seven mutants which contained a substitution
within the region between aa 386 and 393 reacted posi-
tively with mab 3H5 in IFA (Table 2). In contrast, five of TABLE 2
six DEN2 mutants which contained a substitution located
Binding of Mab 3H5 to Chimeric DEN2 Mutant-Infected Cells as
immediately upstream, i.e., E383G, P384E, P384D, Detected by Immunofluorescence or by Radioimmunoprecipitation
P384N, and G385K, failed to bind mab 3H5. This result
Detection by IFA Detection by RIPsuggested that each of the amino acids in the Glu-Pro-
Gly sequence was part of the antigenic site of mab 3H5.
DEN2 Mab DEN2 MabIn addition, RIP of the [35S]methionine-labeled lysate pre-
Virus HMAF 3H5 HMAF 3H5
pared from parent chimeric DEN2, mutant G385S, or
three of the five mutants negative for mab 3H5 binding DEN2a / / / /
E383G / 0 / /bby IFA was performed using mab 3H5 or HMAF (Fig.
P384E / 0 / 02). RIP offered the possibility of detecting binding that
P384D / 0 / 0occurred at a low level. Compared to the parent DEN2
P384N / 0 / 0
E precipitate, binding to the mutant Es was not detected G385K / 0 / /b
or markedly reduced as would be predicted from the G385S / / / /
Q386A / / / /result of IFA. RIP revealed that mutant G385K exhibited
K388T / / / /weak binding to mab 3H5.
L389I / / / /
N390S / / / /Effect of amino acid substitution in E on
N390H / / / /
neutralization by mab 3H5 F392Y / / / /
K393R / / / /The panel of chimeric DEN2 mutants was analyzed for
ability to be neutralized by mab 3H5 or DEN2 HMAF in a DEN2 refers to the chimeric DEN2 which was derived from DEN2-
a plaque-reduction neutralization test (Table 3). Neutral- (PreM-E)/DEN4 cDNA.
b The intensity of the precipitated mutant E was reduced comparedization was performed with a fixed titer of virus in the
to that of the parental cDEN2 E. The binding efficiency of mutant DEN2presence of two different concentrations of neutralizing
E to Mab 3H5 was semiquantitated by image densitometry analysis ofantibodies. DEN2 HMAF at 1000-fold dilution readily neu-
the immunoprecipitated mutant Es relative to the parental DEN2 E. The
tralized the parent chimeric DEN2 and all its derived results calculated for the mutants which contain a substitution in the
mutants. At 1:1000 dilution of mab 3H5, five of seven region between aa 383 and 385 are as follows: mutant E383G, 8%;
P384E, 4%; P384D, 0%; and G385K, 7%.mutants in the group that contained an amino acid substi-
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was isolated. As predicted, the escape mutant failed to
react with mab 3H5 in an immunofocus assay (Okuno et
al., 1979). The cDNA fragment C-PreM-E between the
Bgl II (nt 88) and the XhoI (nt 2342) sites that flanked
the structural protein genes of the monoclonal antibody
resistant mutant was cloned and the nucleotide se-
quence of E determined. The mutant contained three
amino acid substitutions in the DEN2 E: Ile22Met, Met476-
Ile, and Glu383Gly. The first two substitutions are conser-
vative amino acid changes and a mutant containing ei-
ther substitution alone was subsequently constructed
and shown to retain reactivity to mab 3H5 (M. Tadano,
unpublished observations). The Glu383Gly substitution
was same as that introduced into the E383G mutant that
lost the ability to bind mab 3H5.
Binding of mab 3H5 to oligopeptides
We also determined if mab 3H5 would bind to oligo-
peptides containing the Glu-Pro-Gly sequence at aa posi-
tions 383–385. Five nested oligopeptides, each 12 amino
acids in length, that contained the sequence of aa 378–
389, aa 380–391, aa 382–393, aa 384–395, or aa 386–FIG. 2. Detection of antigenic reactivity of mutant DEN2 Es by radio-
immunoprecipitation. The [35S]methionine-labeled lysate was prepared 397 of the DEN2 E, were coated onto microtiter plates
from C6/36 cells infected with the parental chimeric DEN2 or the indi- and tested for their ability to bind mab 3H5 when assayed
cated substitution mutant. RIP was performed using mab 3H5 or DEN2 by ELISA. No binding of mab 3H5 to any of the five
HMAF as a control. The immune precipitates were analyzed by PAGE.
oligopeptides was detected (data not shown). The fiveThe labeled bands showing the dengue virus proteins are indicated.
oligopeptides also failed to bind antibodies in DEN2
HMAF. As a control, binding of DEN4 HMAF to a DEN4 E
peptide containing aa 258–271 was detected. To furtherfold dilution of mab 3H5. With the exception of mutant
validate this result, a binding-competition experiment inG385S, mutants of the other group which contained a
solution was performed. In this binding assay radiola-substitution in the region of aa 383, 384, and 385 were
beled DEN2 E from the parental DEN2 chimera, mutantresistant or partially resistant to neutralization with mab.
Mutant G385K was partially neutralized by mab 3H5 at
a high concentration, consistent with the finding that this
TABLE 3
mutant failed to bind 3H5 in the IFA, but still showed a
Plaque-Reduction Neutralization of Chimeric DEN2 Mutantslow level of binding by RIP. On the basis of this analysis,
by DEN2 HMAF or Mab 3H5five of six mutants in the group containing a substitution
at aa position 383, 384, or 385 of DEN2 E were 3H5 mab Percentage of plaque reduction
escape mutants. The pattern of virus neutralization by
HMAF dilution Mab 3H5 dilution Neutralized3H5 was predicted by the results of the 3H5 binding
by Mabexperiment. We conclude that each of the amino acids
Virus 1:100 1:1000 1:100 1:1000 3H5in the Glu-Pro-Gly sequence at positions 383–385 contri-
butes to the epitope on DEN2 E seen by neutralizing DEN2a 95 95 95 95 Yes
mab 3H5. E383G 95 95 0 0 No
P384E 95 95 0 0 No
P384D 95 95 0 0 NoMab 3H5 escape mutants of chimeric DEN2
P384N 95 95 0 0 No
G385K 95 95 35 0 Yes (weak)To more fully define the site of the mab 3H5 neutraliz-
G385S 95 95 95 70 Yesing epitope, we attempted to isolate monoclonal antibody
Q386A 95 95 95 95 Yes
escape mutants. A preparation of the parental DEN2 chi- K388T 95 95 95 75 Yes
mera that contained the unmodified DEN2 PreM-E genes L389I 95 95 95 95 Yes
N390S 95 95 95 95 Yeson the DEN4 genome background was used for neutral-
N390H 95 95 95 95 Yesization by mab 3H5. Any residual infectious virus follow-
F392Y 95 95 95 60 Yesing neutralization was amplified by infection of C6/36
K393R 95 95 95 95 Yes
cells. This procedure was repeated three times prior to
isolation of clonal populations of virus by plaque purifica- a DEN2 refers to the chimeric DEN2 which was derived from DEN2-
(PreM-E)/DEN4 cDNA.tion on the same cells. One mab 3H5 escape mutant
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TABLE 4 tution at position 383, 384, or 385 of E, previously shown
to be mab 3H5 resistant variants, completely or nearlyMouse Neurovirulence of Chimeric DEN2 Mutants
completely lost neurovirulence for mice. The remainingTested by Intracerebral Inoculation
seven mutants, each of which contained an amino acid
Mortality rate (No. mice tested that died/No. mice substitution in the region between positions 386 and 393
tested) following inoculation with a dose of in E either retained or lost the neurovirulence phenotype
dependent on the substitution. Mutants K388T, L389I,Virus 100 PFU 1000 PFU
N390S, and N390H retained mouse neurovirulence. On
DEN2a 4/10 17/17 (10/10, 7/7)b the other hand, mutants F392Y and K393R showed reduc-
E383G 0/17 (0/9, 0/8) 3/20 (2/10, 1/10) tion of neurovirulence for mice, although each of these
P384E ND 0/8 mutants remained antigenically reactive for mab 3H5.
P384D ND 0/8
P384N 0/8 0/9
G385K 0/10 0/9 DISCUSSION
G385S 6/14 15/18 (7/8, 8/10)
Q386A 0/10 0/10 Monoclonal antibodies specific for flavivirus E glyco-
K388T 13/21 (5/11, 8/10) 23/28 (5/8, 8/10, 10/10) proteins have proven valuable for analysis of the neutral-
L389I 8/18 (5/10, 3/8) 13/18 (8/10, 5/8)
ization epitopes on this major surface antigen (HenchalN390S 6/9 18/19 (8/9, 10/10)
et al., 1985; Mandl et al., 1989; Barrett et al., 1991; GaoN390H 7/10 21/21 (10/10, 11/11)
F392Y 0/9 0/9 et al., 1994; Lin et al., 1994). An examination of a panel
K393R 0/8 0/8 of DEN2 mutants constructed to contain a single amino
acid substitution in E identified the Glu-Pro-Gly sequencea DEN2 refers to chimeric DEN2.
at positions 383–385 of the DEN2 E as a component ofb Where two or more experiments were performed, the results in
the mab 3H5 neutralization epitope. On the basis of theparentheses were used to obtain the cumulative numbers.
recently determined three-dimensional structure of the
TBEV E (Rey et al., 1995), the DEN2 E Glu-Pro-Gly se-
P384E, or L389I was first incubated with the DEN2 oligo- quence is predicted to be located on the lateral surface
peptide (aa 380–391) at 0.001, 0.01, or 0.1 mM prior to as part of the loop flanked by the F and G b strands.
addition of mab 3H5 in RIPA buffer. The result indicated Furthermore, this site is located within the immunoglobu-
that there was no reduction of binding between mab 3H5 lin C-like module (domain III) that has been proposed to
and parental DEN2 E or mutant L389I E even in the serve an essential function in attachment of virus to host
presence of a high concentration of the DEN2 E oligopep- cell receptors. This suggests that mab 3H5 neutralizes
tide (data not shown). Mab 3H5 failed to precipitate E of DEN2 by inhibiting attachment to the cell surface. Unlike
mutant P384E using this assay, as predicted. mab 3H5, most other DEN2 mabs appeared to be non-
neutralizing or poorly neutralizing (Gentry et al., 1982). At
Effects of amino acid substitutions in E on DEN2
present, the antigenic epitopes of these mabs are not
mouse neurovirulence
known. However, analysis of neutralization-resistant mu-
tants of DEN2 mab G8D11 identified Lys309 of E as aIn other prior studies, a number of neutralization-resis-
tant variants of flaviviruses selected by neutralizing component of the neutralization epitope (Lin et al., 1994).
In the three-dimensional flavivirus E structure, Lys309 ismonoclonal antibodies also exhibited reduced neuroviru-
lence for mice (Holzmann et al., 1990; Hasegawa et al., predicted to occupy the top surface of domain III on
the E dimer plane. Thus, judging by the location of this1992; Jiang et al., 1993; McMinn et al., 1995). These find-
ings suggest that certain antigenic determinants on the antigenic determinant, it appears that mab 3H5 and mab
G8D11 define separate epitopes that are both function-flavivirus E are also essential for expression of virulence.
Therefore, it was of interest to determine whether those ally similar with respect to neutralization of infectivity.
The Glu-Pro-Gly sequence at positions 383–385 of EDEN2 E mutations that were shown to alter the antigenic
reactivity with mab 3H5 also affected mouse neuroviru- is conserved among DEN2 strains, but the corresponding
sequence is highly divergent among other dengue viruslence. The parent DEN2 chimera from which the series
of mutants was derived contained the PreM-E genes of serotypes. The finding that the unique DEN2 E sequence
constituted a component of the antigenic site that inter-a mouse neurovirulent DEN2 NGC mutant. Neuroviru-
lence of the parental DEN2 chimera was clearly evident acts with mab 3H5 is consistent with the established
DEN2 specificity of mab 3H5. At corresponding position,at a dose of 1000 PFU, as all mice succumbed to infec-
tion. At a dose of 100 PFU, 4 of 10 mice died after inocula- an Arg-Gly-Asp (also termed R-G-D) sequence is present
in the E of yellow fever virus, Murray Valley encephalitistion with this virus (Table 4) and two of the survivors
became paralyzed. The series of DEN2 mutants was ana- (MVE) virus, or other members of the West Nile flavivirus
group. There is evidence suggesting that the R-G-D se-lyzed similarly for mouse neurovirulence by intracerebral
inoculation of a dose of 100 or 1000 PFU. With the excep- quence may be a determinant for host cell tropism. First,
serial passage of the MVE virus in human SW13 cellstion of mutant G385S, mutants which contained a substi-
AID VY 8179 / 6a20$$$$63 09-16-96 15:19:52 viral AP: Virology
444 HIRAMATSU ET AL.
invariably selected mutants that contained a substitution pared to its neurovirulent parent. Reduction of DEN2
mouse neurovirulence and resistance to mab 3H5 neu-of the Asp residue in the R-G-D sequence (Lobigs et
al., 1990). Also, the presence of an R-G-D sequence is tralization appear to be coordinate properties of these
mutants. This suggests that the DEN2 E Glu-Pro-Gly se-associated with the cell attachment activity of a number
of cellular as well as viral proteins (Ruoslahti and quence at aa 383–385 also represents a determinant of
DEN2 mouse neurovirulence. Studies of mab resistantPierschbacher, 1987; Bork et al., 1994). Interestingly, the
DEN2 Glu-Pro-Gly sequence or the corresponding se- variants of TBEV or other flaviviruses also identified
shared determinants of mouse neurovirulence and neu-quence of other mosquito-borne flaviviruses is deleted
among members of the tick-borne encephalitis virus tralization epitopes on the E glycoprotein (Holzmann et
al., 1990; Hasegawa et al., 1992; Jiang et al., 1993).group. It remains to be determined whether the presence
or absence of the presumptive attachment site sequence Comparison of the amino acid sequences in the C-
PreM-E structural proteins between the prototype, non-on the E surface plays a role in the vertebrate vector
preference of the mosquito-borne and the tick-borne flav- neurovirulent DEN2 NGC strain and its mouse-adapted
neurovirulent mutant indicated that substitution of Glu foriviruses.
Detection of binding of mab 3H5 to the DEN2 E peptide Lys126 (DEN2 polyprotein aa 406) in E played an essential
role in DEN2 mouse neurovirulence (M. Bray, unpub-in the region between aa 386 and 397 by ELISA, reported
earlier (Trirawantanapong et al., 1992), was not con- lished observations; Chen et al., 1995). In the three-di-
mensional structure of the flavivirus E, Lys126 is locatedfirmed in the current study. Mab 3H5 also failed to bind
to a series of other oligopeptides of the upstream DEN2 at the top of the d–e loop extending outward from the
center of the E dimer plane within domain II. This locusE sequence that contained the Glu-Pro-Gly sequence.
Consistent with this result was the finding that binding responsible for DEN2 mouse neurovirulence appears to
be spatially separate from the Glu-Pro-Gly sequenceof mab 3H5 to radiolabeled Es in solution was not re-
duced in the presence of the DEN2 oligopeptide (aa 380 – which also played a role in neurovirulence for mice. Thus,
two apparently different loci in separate antigenic do-391) that contained the Glu-Pro-Gly sequence. This is
probably not surprising because mab 3H5 might recog- mains on the surface of DEN2 E have been identified as
the determinants of DEN2 mouse neurovirulence. Muta-nize a sequence that is highly dependent on conforma-
tion. It is highly probable that mutations in the loop region tion in either of these loci that results in attenuation of
dengue virus mouse neurovirulence is probably a conse-connecting the f and g strands are likely to have perturba-
tions in the peptide strand interactions, including assem- quence of reduced replicative capacity in the central ner-
vous system of mice. It remains to be tested if any ofbly of E protein dimers from the monomers. Thus, such
mutations can critically affect the overall conformation of these DEN2 mutations that effect reduced mouse neuro-
virulence has a bearing on attenuation for humans.the region between aa 383 and 393 and the stability of
the E dimers (Bennet et al., 1995). This notion is consis-
tent with the molecular structure of E, which reveals that
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